Page last updated: 2024-11-06

piperonyl butoxide and Abnormalities, Drug-Induced

piperonyl butoxide has been researched along with Abnormalities, Drug-Induced in 5 studies

Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.

Research Excerpts

ExcerptRelevanceReference
"Piperonyl butoxide was administered to pregnant mice by gavage at a level of 0 (control), 1065, 1385 and 1800 mg/kg body weight only on day 9 of gestation."3.69Developmental toxicity evaluation of piperonyl butoxide in CD-1 mice. ( Fujitani, T; Oishi, S; Takahashi, O; Tanaka, T, 1994)
"Cyclophosphamide reduced fetal body weights by 30-40% without increasing resorption or death."1.35Preventive effect of piperonyl butoxide on cyclophosphamide-induced teratogenesis in rats. ( Choi, YJ; Jang, JY; Joo, SS; Kang, H; Kim, KY; Kim, S; Kim, TK; Kim, YB; Lee, SH; Oh, J; Park, D; Shin, S, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, D1
Kim, S1
Kang, H1
Oh, J1
Jang, JY1
Shin, S1
Kim, TK1
Choi, YJ1
Lee, SH1
Kim, KY1
Joo, SS1
Kim, YB1
Hilscherova, K2
Blankenship, AL2
Nie, M2
Coady, KK2
Upham, BL1
Trosko, JE1
Giesy, JP2
Villalobos, SA1
Kannan, K1
Powell, DC1
Bursian, SJ1
Tanaka, T1
Fujitani, T1
Takahashi, O1
Oishi, S1
Khera, KS1
Whalen, C1
Angers, G1
Trivett, G1

Other Studies

5 other studies available for piperonyl butoxide and Abnormalities, Drug-Induced

ArticleYear
Preventive effect of piperonyl butoxide on cyclophosphamide-induced teratogenesis in rats.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2009, Volume: 86, Issue:5

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Bone Development; Cyclophosphamide; Cyto

2009
Oxidative stress in liver and brain of the hatchling chicken (Gallus domesticus) following in ovo injection with TCDD.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2003, Volume: 136, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Antioxidants; Brain; Chick Embryo; Chickens; DNA Damage; Drug

2003
Mechanisms of TCDD-induced abnormalities and embryo lethality in white leghorn chickens.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2003, Volume: 136, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Chick Embryo; Chickens; Cytochrome P-450 CYP1A1; Drug Combinat

2003
Developmental toxicity evaluation of piperonyl butoxide in CD-1 mice.
    Toxicology letters, 1994, Volume: 71, Issue:2

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Behavior, Animal; Body Weight; Dose-Resp

1994
Assessment of the teratogenic potential of piperonyl butoxide, biphenyl, and phosalone in the rat.
    Toxicology and applied pharmacology, 1979, Volume: 47, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Biphenyl Compounds; Female; Fetus; Gestational Age; Insecticid

1979